Alpha Tau Medical (NASDAQ:DRTSW) Stock Price Up 12.4%
Alpha Tau Medical (NASDAQ:DRTSW) Stock Price Up 12.4%
Shares of Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Rating) rose 12.4% during trading on Thursday . The stock traded as high as $0.25 and last traded at $0.25. Approximately 975 shares were traded during trading, a decline of 94% from the average daily volume of 15,412 shares. The stock had previously closed at $0.22.
Alpha Tau Medical Ltd.（納斯達克股票代碼：DRTSW — 獲取評級）的股價在週四的交易中上漲了12.4％。該股交易價格高達0.25美元，最後一次交易價格爲0.25美元。交易期間交易了約975股，較平均每日交易量15,412股下降了94％。該股此前收於0.22美元。
Alpha Tau Medical Trading Up 12.4 %
Alpha Tau Medical 交易量上漲了
The firm has a fifty day simple moving average of $0.33 and a 200 day simple moving average of $0.33.
該公司的五十天簡單移動平均線爲0.33美元，200天簡單移動平均線爲0.33美元。
Institutional Investors Weigh In On Alpha Tau Medical
機構投資者對 Alpha Tau Medical 加
Several hedge funds and other institutional investors have recently modified their holdings of the stock. Polar Asset Management Partners Inc. acquired a new stake in shares of Alpha Tau Medical in the first quarter worth $134,000. Walleye Capital LLC lifted its position in Alpha Tau Medical by 10.9% in the second quarter. Walleye Capital LLC now owns 204,285 shares of the company's stock worth $98,000 after purchasing an additional 20,096 shares during the period. Whitebox Advisors LLC bought a new position in Alpha Tau Medical in the third quarter worth $65,000. Chicago Partners Investment Group LLC bought a new position in Alpha Tau Medical in the first quarter worth $55,000. Finally, LMR Partners LLP lifted its position in Alpha Tau Medical by 67.4% in the third quarter. LMR Partners LLP now owns 112,986 shares of the company's stock worth $660,000 after purchasing an additional 45,500 shares during the period.
幾家對沖基金和其他機構投資者最近修改了他們對該股的持有量。Polar Asset Management Partners Inc. 在第一季度收購了價值13.4萬美元的Alpha Tau Medical股票Walleye Capital LLC在第二季度將其在Alpha Tau Medical的頭寸提高了10.9％。Walleye Capital LLC在此期間又購買了20,096股股票後，現在擁有該公司204,285股股票，價值98,000美元。Whitebox Advisors LLC在第三季度收購了Alpha Tau Medical的新職位，價值65,000美元芝加哥合夥人投資集團有限責任公司在第一季度收購了Alpha Tau Medical的新頭寸，價值55,000美元。最後，LMR Partners LLP在第三季度將其在Alpha Tau Medical的頭寸提高了67.4％。LMR Partners LLP在此期間又購買了45,500股股票後，現在擁有該公司價值66萬美元的112,986股股票。
Alpha Tau Medical Company Profile
Alpha Tau 醫療公司簡介
(Get Rating)
（獲取評分）
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, lung, and prostate cancers.
Alpha Tau Medical Ltd. 是一家臨牀階段的腫瘤治療公司，在以色列和美國從事用於治療實體癌的彌散α-發射體放射療法（Alpha DarT）的研究、開發和商業化。其 Alpha-DART 技術用於皮膚癌、口腔癌、胰腺癌和乳腺癌的臨牀試驗；以及肝細胞癌、肺癌和前列腺癌的臨牀前研究。
Read More
閱讀更多
- Get a free copy of the StockNews.com research report on Alpha Tau Medical (DRTSW)
- Finding New Technology to Invest in: A Guide
- Genuine Parts Company Is Genuinely A Good Buy
- Healthcare Sector: Overview and Keys to Investing
- Can D.R. Horton Shares Raise The Roof, Or Is This The Ceiling?
- American Express Growth Riding On Joyful Consumer Spending
- 免費獲取 StockNews.com 關於 Alpha Tau Medical (DRTSW) 的研究報告的副本
- 尋找可供投資的新技術：指南
- 正品零件公司確實是個不錯的選擇
- 醫療保健行業：概述和投資關鍵
- D.R. Horton 的股票能否抬高屋頂，還是這是上限？
- 美國運通的增長取決於愉快的消費者支出
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Alpha Tau 醫學日報的新聞和評級 -在下面輸入您的電子郵件地址，通過Marketbeat.com的免費每日電子郵件時事通訊接收Alpha Tau Medical及相關公司的最新新聞和分析師評級的簡明每日摘要。
譯文內容由第三人軟體翻譯。